Healthcare

ESPERION THERAPEUTICS INC

Ticker: ESPR
Exchange: US
Composite FIGI: BBG004KB3S72

Total Alternative Signals

2signals tracked

Weighted Sentiment

+0.54weighted index

Avg Materiality Score

4.0/ 5.0 scale

Signal Distribution

1|1|0

Alternative Data Signal Feed

Real-Time Ingestion Active

Unlock Alternative Signals Feed

Access the complete, parsed materiality analysis, long-term investment theses, and direct feed links for ESPERION THERAPEUTICS INC. Programmatic API and Webhooks available.

Talent PivotNeutral
Filing Date: 2026-06-16

Signal Event Report - FIGI BBG004KB3S72

Esperion Therapeutics filed a current report detailing changes in directors or officers (Item 5.02) and matters submitted to a vote of security holders (Item 5.07), indicating potential shifts in leadership or governance.

Quantitative Investment Thesis

Changes in key personnel can signal a strategic shift or an effort to bring in new expertise, potentially impacting future performance and the company's long-term direction.

Materiality & Sentiment Scores
Sentiment: 0.2
Materiality: 3 / 5
Source Document: https://www.sec.gov/Archives/edgar/data/1434868/0001628280-26-039518-index.htm
Strategic PartnershipBullish
Filing Date: 2026-06-16

Signal Event Report - FIGI BBG004KB3S72

Esperion Therapeutics filed a definitive proxy statement related to a merger or acquisition, indicating a significant strategic move to potentially expand its market or product portfolio.

Quantitative Investment Thesis

This event suggests a transformative corporate action that could significantly alter the company's competitive landscape and growth trajectory, making the long-term investment case more attractive.

Materiality & Sentiment Scores
Sentiment: 0.75
Materiality: 5 / 5
Source Document: https://www.sec.gov/Archives/edgar/data/1434868/0001104659-26-071107-index.htm